ANIK
Anika Therapeutics Inc
$25.58
Earnings Summary
Revenue | $42.97Mn |
Net Profits | $-63Mn |
Net Profit Margins | -146.61% |
Highlights
Anika Therapeutics Inc’s revenue jumped 8.45% since last year same period to $42.97Mn in the Q4 2023. On a quarterly growth basis, Anika Therapeutics Inc has generated 3.63% jump in its revenue since last 3-months.
Anika Therapeutics Inc’s net profit fell -1183.62% since last year same period to $-63Mn in the Q4 2023. On a quarterly growth basis, Anika Therapeutics Inc has generated -858.03% fall in its net profits since last 3-months.
Anika Therapeutics Inc’s net profit margin fell -1083.58% since last year same period to -146.61% in the Q4 2023. On a quarterly growth basis, Anika Therapeutics Inc has generated -824.45% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Anika Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.11 |
EPS Estimate Current Year | -0.11 |
Highlights
Anika Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.11 - a 57.69% jump from last quarter’s estimates.
Anika Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.11.
Key Ratios
Key ratios of the Anika Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -4.3 |
Highlights
Anika Therapeutics Inc’s earning per share (EPS) fell -1164.71% since last year same period to -4.3 in the Q4 2023. This indicates that the Anika Therapeutics Inc has generated -1164.71% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-09 | -0.3 | -0.47 | -56.67% |
2023-08-08 | -0.27 | -0.19 | 29.63% |
2024-03-15 | -0.26 | -4.3 | -1553.85% |
2023-11-03 | -0.37 | -0.45 | -21.62% |
₹0 US Stocks a/c Opening Fee